Nu Skin Enterprises, Inc. develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products. The company also offers ageLOC Youth nutritional supplements, ageLOC TR90 weight management and body shaping systems, and LifePak nutritional supplements, as well as other anti-aging nutritional solutions and weight management products. In addition, it is involved in the research and product development of skin care products and nutritional supplements. Further, the company operates walk-in centers and pick-up locations; and retail stores and service centers in Mainland China. The company sells its products directly, as well as through distributors and Website. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
Industry, Sector and Symbol
Stock Exchange NYSE
Industry Drugs, proprietaries, & sundries
Sub-IndustryPersonal Products
SectorConsumer Staples
Current SymbolNYSE:NUS
Previous Symbol
CUSIP67018T10
Phone801-345-1000
Debt
Debt-to-Equity Ratio0.44
Current Ratio1.93
Quick Ratio1.25
Price-To-Earnings
Trailing P/E Ratio19.75
Forward P/E Ratio18.17
P/E Growth1.63
Sales & Book Value
Annual Sales$2.28 billion
Price / Sales1.55
Cash Flow$4.7008 per share
Price / Cash Flow13.57
Book Value$13.40 per share
Price / Book4.76
Profitability
EPS (Most Recent Fiscal Year)$3.23
Net Income$129.43 million
Net Margins5.93%
Return on Equity27.50%
Return on Assets12.59%
Miscellaneous
Employees4,700
Outstanding Shares55,550,000
Market Cap$3.56 billion
OptionableOptionable
Nu Skin Enterprises (NYSE:NUS) Frequently Asked Questions
What is Nu Skin Enterprises' stock symbol?
Nu Skin Enterprises trades on the New York Stock Exchange (NYSE) under the ticker symbol "NUS."
How often does Nu Skin Enterprises pay dividends? What is the dividend yield for Nu Skin Enterprises?
Nu Skin Enterprises declared a quarterly dividend on Thursday, November 8th. Shareholders of record on Friday, November 30th will be given a dividend of $0.365 per share on Wednesday, December 12th. This represents a $1.46 annualized dividend and a yield of 2.29%. The ex-dividend date is Thursday, November 29th. View Nu Skin Enterprises' Dividend History.
How were Nu Skin Enterprises' earnings last quarter?
Nu Skin Enterprises, Inc. (NYSE:NUS) posted its earnings results on Wednesday, November, 7th. The company reported $0.94 earnings per share for the quarter, missing analysts' consensus estimates of $0.96 by $0.02. The firm earned $675.31 million during the quarter, compared to analyst estimates of $664.99 million. Nu Skin Enterprises had a return on equity of 27.50% and a net margin of 5.93%. The business's revenue for the quarter was up 19.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.76 earnings per share. View Nu Skin Enterprises' Earnings History.
When is Nu Skin Enterprises' next earnings date?
What guidance has Nu Skin Enterprises issued on next quarter's earnings?
Nu Skin Enterprises updated its fourth quarter earnings guidance on Wednesday, November, 7th. The company provided earnings per share (EPS) guidance of $1.04-1.11 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.13. The company issued revenue guidance of $665-685 million, compared to the consensus revenue estimate of $665.95 million.
What price target have analysts set for NUS?
8 brokerages have issued 1-year price objectives for Nu Skin Enterprises' shares. Their predictions range from $65.00 to $92.00. On average, they anticipate Nu Skin Enterprises' share price to reach $82.00 in the next year. This suggests a possible upside of 28.5% from the stock's current price. View Analyst Price Targets for Nu Skin Enterprises.
What is the consensus analysts' recommendation for Nu Skin Enterprises?
8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nu Skin Enterprises in the last year. There are currently 1 sell rating, 2 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Nu Skin Enterprises.
What are Wall Street analysts saying about Nu Skin Enterprises stock?
Here are some recent quotes from research analysts about Nu Skin Enterprises stock:
- 1. According to Zacks Investment Research, "Nu Skin’s shares have underperformed the industry in the past three months, thanks to dismal gross margins and adverse impacts from currency fluctuations. In fact, the company’s gross margin has been slipping since the past several quarters. This emerges as a considerable threat to profitability. Further, Nu Skin’s bottom-line in the third-quarter of 2018 was hurt by foreign currency woes. Sadly, management expects currency translations to dent earnings in 2018. On the bright side, Nu Skin has been steadily gaining from expanding sales leaders and customers globally. Notably, these upsides aided third-quarter results, marking Nu Skin’s fourth consecutive period of year-on-year top- and bottom-line growth. Moreover, the stellar quarterly show encouraged management to raise 2018 revenue projections. Additionally, the company is on track with expanding its sales compensation program Velocity across different nations." (12/11/2018)
- 2. Jefferies Financial Group Inc analysts commented, "We hosted NUS senior leaders for a series of meetings last week. While our view of China macro beauty has tempered somewhat in recent months, we walked away from meetings with a more optimistic sense of China skincare device sales potential and global benefits from product innovation (new & extensions), program enhancements (including sales comp structure), and a growing level of sophistication around social selling that sets NUS apart from other MLM companies." (9/4/2018)
Has Nu Skin Enterprises been receiving favorable news coverage?
News coverage about NUS stock has trended somewhat positive recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Nu Skin Enterprises earned a media sentiment score of 1.2 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an effect on the stock's share price in the next several days.
Who are some of Nu Skin Enterprises' key competitors?
Who are Nu Skin Enterprises' key executives?
Nu Skin Enterprises' management team includes the folowing people:
- Mr. Steven J. Lund, Exec. Chairman (Age 65)
- Mr. Ritch N. Wood, CEO & Director (Age 52)
- Mr. Ryan S. Napierski, Pres (Age 44)
- Mr. Mark H. Lawrence, Exec. VP & CFO
- Dr. Joseph Y. Chang, Exec. VP of Product Devel. & Chief Scientific Officer (Age 65)
Who are Nu Skin Enterprises' major shareholders?
Nu Skin Enterprises' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Vanguard Group Inc (12.09%), Vanguard Group Inc. (12.09%), BlackRock Inc. (10.91%), AQR Capital Management LLC (2.62%), William Blair Investment Management LLC (2.27%) and Dimensional Fund Advisors LP (1.97%). Company insiders that own Nu Skin Enterprises stock include D Matthew Dorny, Daniel W Campbell, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Institutional Ownership Trends for Nu Skin Enterprises.
Which institutional investors are selling Nu Skin Enterprises stock?
NUS stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, AQR Capital Management LLC, TIAA CREF Investment Management LLC, JPMorgan Chase & Co., JPMorgan Chase & Co., Credit Suisse AG, BlackRock Inc. and Vanguard Group Inc.. Company insiders that have sold Nu Skin Enterprises company stock in the last year include D Matthew Dorny, Edwina D Woodbury, Joseph Y Chang, Mark H Lawrence, Neil H Offen, Pisano R Thomas, Ryan S Napierski and Steven Lund. View Insider Buying and Selling for Nu Skin Enterprises.
Which institutional investors are buying Nu Skin Enterprises stock?
NUS stock was purchased by a variety of institutional investors in the last quarter, including Los Angeles Capital Management & Equity Research Inc., Assenagon Asset Management S.A., Point72 Asset Management L.P., WINTON GROUP Ltd, Acadian Asset Management LLC, Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, William Blair Investment Management LLC and Prudential Financial Inc.. View Insider Buying and Selling for Nu Skin Enterprises.
How do I buy shares of Nu Skin Enterprises?
Shares of NUS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nu Skin Enterprises' stock price today?
One share of NUS stock can currently be purchased for approximately $63.79.
How big of a company is Nu Skin Enterprises?
Nu Skin Enterprises has a market capitalization of $3.56 billion and generates $2.28 billion in revenue each year. The company earns $129.43 million in net income (profit) each year or $3.23 on an earnings per share basis. Nu Skin Enterprises employs 4,700 workers across the globe.
What is Nu Skin Enterprises' official website?
How can I contact Nu Skin Enterprises?
Nu Skin Enterprises' mailing address is 75 WEST CENTER ST, PROVO UT, 84601. The company can be reached via phone at 801-345-1000 or via email at [email protected]
MarketBeat Community Rating for Nu Skin Enterprises (NYSE NUS)
MarketBeat's community ratings are surveys of what our community members think about Nu Skin Enterprises and other stocks. Vote "Outperform" if you believe NUS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NUS will underperform the S&P 500 over the long term. You may vote once every thirty days.
